Get started
Work

Identifying strategies to target the metabolic flexibility of tumours

Year: 2020
Type: article
DOI: 10.1038/s42255-020-0195-8
Authors: Andrés Méndez-Lucas, Wei Lin, Paul C. Driscoll, Nathalie Legrave, Laura Novellasdemunt, Chencheng Xie, Mark Charles, Zena Wilson, Neil P. Jones, Stephen Rayport, Manuel Rodríguez-Justo, Vivian Li, James I. MacRae, Nissim Hay, Xin Chen, Mariia Yuneva
Institutions: The Francis Crick Institute, University of South Dakota, Cancer Research UK, AstraZeneca (United Kingdom), New York State Psychiatric Institute, Columbia University, University College London, University of Illinois Chicago, University of California, San Francisco
Language: English
Subfield: Cancer Research
Open Access status: green
Funders: U.S. Department of Health and Human Services, U.S. Department of Veterans Affairs, Wellcome Trust, Francis Crick Institute, Cancer Research UK, National Institutes of Health, Medical Research Council, National Institute on Aging, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: G1195536806, G180086439, G2302920545, G2679391123, Hexokinase 2 in liver cancer, G2793002436, G301531054, G3283800817, G3768580956, G4002584958, G4369566659, G5980734565, G6552052660, Glutamine catabolism in c-Myc driven liver tumor development, G6846731920, G72484420, G7944063001, G8577269960, G8754390065, Molecular Genetics of Liver Cancers, G8827280393, G8923178809, G9000019777, G9000038837, G9000060476, G9000131546, UCSF Liver Center
OpenAlex ID: W3018515813
FWCI: 6.036
Cites: 71
Cited by: 142
Related to: 10